We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 1)

Figure 1). From: Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Score amelioration of the attention-deficit hyperactivity disorder (ADHD) children according to their n-3 polyunsaturated fatty acid (PUFA) levels. ADHD patients (n=26, who completed the study) have been distributed into three categories: light (±), good (+) and very good (++) clinical improvement, taking into account the percentage level of the three major n-3 fatty acids (alpha-linolenic acid [ALA], eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]). Comparisons were performed before the first phase or baseline (0) and after the second phase. The statistical values relative to the relationship between n-3 PUFA and improvement scores are ALA 0.489, EPA 0.055 and DHA 0.060

Stacey Ageranioti Bélanger, et al. Paediatr Child Health. 2009 February;14(2):89-98.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk